ArticleFrontiers in immunology2025

Elevated serum IL-10/IL-6 ratio as a novel biomarker for secondary central nervous system lymphoma and poor prognosis in DLBCL.

Jingjing Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.